归巢穿膜肽的研究进展
Research Advances of Homing Penetrating Peptide
DOI: 10.12677/ACM.2021.1111722, PDF,   
作者: 苏 畅：济宁医学院临床医学院，山东 济宁；梁秋华：济宁医学院附属医院内分泌科，山东 济宁；孙 琳*：济宁市第一人民医院内分泌科，山东 济宁
关键词: 噬菌体展示技术；归巢穿膜肽；靶向治疗；临床应用；Phage Display Technology； Homing Penetrating Peptide； Targeted Therapy； Clinical Application
摘要: 归巢肽是伴随噬菌体展示技术的发展而被证实具有归巢作用的多肽，它能特异性地识别和结合一些受体或标志物。研究表明，部分归巢肽还具有穿膜特性，能够使蛋白质、RNA、DNA等生物大分子特异性进入到细胞或者组织内发挥作用，在临床诊断和治疗中具有高效性、特异性等优势。本文简要综述对归巢穿膜肽的概述、筛选、分类以及在临床诊断及治疗应用中所获得的研究进展。
Abstract: Homing peptide is a polypeptide that has been confirmed to have a homing effect with the development of phage display technology. It can specifically recognize and bind to some receptors or markers. Studies have shown that some homing peptides also have membrane-penetrating properties, allowing biological macromolecules such as protein, RNA, DNA, etc. to specifically enter cells or tissues to play a role, and have the advantages of high efficiency and specificity in clinical diagnosis and treatment. This article briefly reviews the overview, screening, classification of homing penetrating peptide and the research progress obtained in clinical diagnosis and therapeutic applications.
文章引用：苏畅, 梁秋华, 孙琳. 归巢穿膜肽的研究进展[J]. 临床医学进展, 2021, 11(11): 4919-4925. https://doi.org/10.12677/ACM.2021.1111722

参考文献

[1] Zhang, D., Wang, J. and Xu, D. (2016) Cell-Penetrating Peptides as Noninvasive Transmembrane Vectors for the Development of Novel Multifunctional Drug-Delivery Systems. Journal of Controlled Release, 229, 130-139. [Google Scholar] [CrossRef] [PubMed]
[2] Kurrikoff, K., Vunk, B. and Langel, Ü. (2021) Status Update in the Use of Cell-Penetrating Peptides for the Delivery of Macromolecular Therapeutics. Expert Opinion on Biological Therapy, 21, 361-370. [Google Scholar] [CrossRef] [PubMed]
[3] He, B., Dzisoo, A.M., Derda, R. and Huang, J. (2019) Development and Application of Computational Methods in Phage Display Technology. Current Medicinal Chemistry, 26, 7672-7693. [Google Scholar] [CrossRef] [PubMed]
[4] He, B., Jiang, L., Duan, Y., Chai, G., Fang, Y., Kang, J., et al. (2018) Biopanning Data Bank 2018: Hugging Next Generation Phage Display. Database, 2018, Article No. bay032. [Google Scholar] [CrossRef] [PubMed]
[5] 郭超, 左琪, 杨晓峰, 张帆. 体内噬菌体展示技术筛选人髓样乳腺癌Bcap-37细胞特异性结合肽及其性质、结合效果研究[J]. 肿瘤研究与临床, 2020, 32(2): 79-84.
[6] 梅隽彦. 基于细胞穿膜肽的药物递送研究进展[J]. 广州化学, 2020, 45(2): 64-75.
[7] Guidotti, G., Brambilla, L. and Rossi, D. (2017) Cell-Penetrating Peptides: From Basic Research to Clinics. Trends in Pharmacological Sciences, 38, 406-424. [Google Scholar] [CrossRef] [PubMed]
[8] 彭志荣, 夏新华, 颜红. 细胞穿透肽修饰脂质体的抗肿瘤靶向给药研究进展[J]. 中国肿瘤生物治疗杂志, 2019, 26(11): 1275-1280.
[9] Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R.L., Torre, L.A. and Jemal, A. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinician, 68, 394-424. [Google Scholar] [CrossRef] [PubMed]
[10] 谢洋洋, 王邵娟, 袁权, 夏宁邵. 细胞穿膜肽研究应用的新进展[J]. 生物工程学报, 2019, 35(7): 1162-1173.
[11] Diakova, G.B., Du, Z. and Klibanov, A.L. (2020) Targeted Ultrasound Contrast Imaging of Tumor Vasculature with Positively Charged Microbubbles. Investigative Radiology, 55, 736-740. [Google Scholar] [CrossRef] 
[12] Stanzl, E.G., Trantow, B.M., Vargas, J.R. and Wender, P.A. (2013) Fifteen Years of Cell-Penetrating, Guanidinium-Rich Molecular Transporters: Basic Science, Research Tools, and Clinical Applications. Accounts of Chemical Research, 46, 2944-2954. [Google Scholar] [CrossRef] [PubMed]
[13] Nguyen, L.T., Yang, X.Z., Du, X., Wang, J.-W., Zhang, R., Zhao, J., et al. (2015) Enhancing Tumor-Specific Intracellular Delivering Efficiency of Cell-Penetrating Peptide by Fusion with a Peptide Targeting to EGFR. Amino Acids, 47, 997-1006. [Google Scholar] [CrossRef] [PubMed]
[14] Lindgren, M., Rosenthal-Aizman, K., Saar, K., Eiríksdóttir, E., Jiang, Y., Sassian, M., et al. (2006) Overcoming Methotrexate Resistance in Breast Cancer Tumour Cells by the Use of a New Cell-Penetrating Peptide. Biochemical Pharmacology, 71, 416-425. [Google Scholar] [CrossRef] [PubMed]
[15] Xu, Y.Y., Cao, X.W., Fu, L.Y., Zhang, T.-Z., Wang, F.-J. and Zhao, J. (2019) Screening and Characterization of a Novel High-Efficiency Tumor-Homing Cell-Penetrating Peptide from the Buffalo Cathelicidin Family. Journal of Peptide Science, 25, Article No. e3201. [Google Scholar] [CrossRef] [PubMed]
[16] Laakkonen, P. and Vuorinen, K. (2010) Homing Peptides as Targeted Delivery Vehicles. Integrative Biology, 2, 326-337. [Google Scholar] [CrossRef] [PubMed]
[17] Sugahara, K.N., Teesalu, T., Karmali, P.P., Kotamraju, V.R., Agemy, L., Girard, O.M., et al. (2009) Tissue-Penetrating Delivery of Compounds and Nanoparticles into Tumors. Cancer Cell, 16, 510-520. [Google Scholar] [CrossRef] [PubMed]
[18] Song, Y., Xu, M., Li, Y., Li, Y., Gu, W., Halimu, G., et al. (2020) An iRGD Peptide Fused Superantigen Mutant Induced Tumor-Targeting and T Lymphocyte Infiltrating in Cancer Immunotherapy. International Journal of Pharmaceutics, 586, Article ID: 119498. [Google Scholar] [CrossRef] 
[19] Reissmann, S. and Filatova, M.P. (2021) New Generation of Cell-Penetrating Peptides: Functionality and Potential Clinical Application. Journal of Peptide Science, 27, Article No. e3300. [Google Scholar] [CrossRef] [PubMed]
[20] Ciobanasu, C., Dragomir, I. and Apetrei, A. (2019) The Penetrating Properties of the Tumor Homing Peptide LyP-1 in Model Lipid Membranes. Journal of Peptide Science, 25, Article No. e3145. [Google Scholar] [CrossRef] [PubMed]
[21] Jiang, W., Jin, G., Ma, D., Wang, F., Fu, T., Chen, X., et al. (2012) Modification of Cyclic NGR Tumor Neovasculature-Homing Motif Sequence to Human Plasminogen Kringle 5 Improves Inhibition of Tumor Growth. PLoS ONE, 7, Article ID: e37132. [Google Scholar] [CrossRef] [PubMed]
[22] Araki, D., Takayama, K., Inoue, M., Watanabe, T., Kumon, H., Futaki, S., et al. (2010) Cell-Penetrating D-Isomer Peptides of p53 C-Terminus: Long-Term Inhibitory Effect on the Growth of Bladder Cancer. Urology, 75, 813-819. [Google Scholar] [CrossRef] [PubMed]
[23] Kang, R.H., Jang, J.E., Huh, E., Kang, S.J., Ahn, D.-R., Kang, J.S., et al. (2020) A Brain Tumor-Homing Tetra-Peptide Delivers a Nano-Therapeutic for More Effective Treatment of a Mouse Model of Glioblastoma. Nanoscale Horizons, 5, 1213-1225. [Google Scholar] [CrossRef] 
[24] Zhang, D., Chu, Y., Qian, H., Qian, L., Shao, J., Xu, Q., et al. (2020) Antitumor Activity of Thermosensitive Hydrogels Packaging Gambogic Acid Nanoparticles and Tumor-Penetrating Peptide iRGD against Gastric Cancer. International Journal of Nanomedicine, 15, 735-747. [Google Scholar] [CrossRef] 
[25] Hurtado de Mendoza, T., Mose, E.S., Botta, G.P., Braun, G.B., Kotamraju, V.R., French, R.P., et al. (2021) Tumor-Penetrating Therapy for β5 Integrin-Rich Pancreas Cancer. Nature Communications, 12, Article No. 1541. [Google Scholar] [CrossRef] [PubMed]
[26] iRGD-Liposomes Enhance Tumor Delivery and Therapeutic.
[27] Kida, S., Eto, Y., Yoshioka, Y., Nakagawa, S., Kawasaki, K. and Maeda, M. (2010) Evaluation of Synthetic Cell-Penetrating Peptides, Pro-Rich Peptide and Octaargine Derivatives, as Adenovirus Vector Carrier. Protein & Peptide Letters, 17, 164-167. [Google Scholar] [CrossRef] [PubMed]
[28] Zhang, J.F., Xiong, H.L., Cao, J.L., Wang, S.J., Guo, X.R., Lin, B.Y., et al. (2018) A Cell-Penetrating Whole Molecule Antibody Targeting Intracellular HBx Suppresses Hepatitis B Virus via TRIM21-Dependent Pathway. Theranostics, 8, 549-562. [Google Scholar] [CrossRef] [PubMed]
[29] Tian, T., Song, Y., Li, K., Sun, Y. and Wang, Q. (2018) Synthesis, Characterization, and Evaluation of Triptolide Cell-Penetrating Peptide Derivative for Transdermal Delivery of Triptolide. Molecular Pharmaceutics, 15, 560-570. [Google Scholar] [CrossRef] [PubMed]
[30] 夏艳梅, 于思远, 杨晗, 李廷栋. 细胞穿膜肽介导生物大分子入胞机制研究进展[J]. 中国生物工程杂志, 2019, 39(10): 82-89.
[31] van der Schot, G. and Bonvin, A.M. (2015) Performance of the WeNMR CS-Rosetta3 Web Server in CASD-NMR. Journal of Biomolecular NMR, 62, 497-502. [Google Scholar] [CrossRef] [PubMed]
[32] Copolovici, D.M., Langel, K., Eriste, E. and Langel, Ü. (2014) Cell-Penetrating Peptides: Design, Synthesis, and Applications. ACS Nano, 8, 1972-1994. [Google Scholar] [CrossRef] [PubMed]
[33] Hagberg, H., Mallard, C., Ferriero, D.M., Vannucci, S.J., Levison, S.W., Vexler, Z.S., et al. (2015) The Role of Inflammation in Perinatal Brain Injury. Nature Reviews Neurology, 11, 192-208. [Google Scholar] [CrossRef] [PubMed]
[34] Kardani, K. and Bolhassani, A. (2021) Exploring Novel and Potent Cell Penetrating Peptides in the Proteome of SARS-COV-2 Using Bioinformatics Approaches. PLoS ONE, 16, Article ID: e0247396. [Google Scholar] [CrossRef] [PubMed]
[35] Gessner, I. and Neundorf, I. (2020) Nanoparticles Modified with Cell-Penetrating Peptides: Conjugation Mechanisms, Physicochemical Properties, and Application in Cancer Diagnosis and Therapy. International Journal of Molecular Sciences, 21, Article No. 2536. [Google Scholar] [CrossRef] [PubMed]

为你推荐